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Background: The nature of multiple organ dysfunction syndrome (MODS) after traumatic injury is
evolving as resuscitation practices advance and more patients survive their injuries to reach critical care.
The aim of this study was to characterize contemporary MODS subtypes in trauma critical care at a
population level.
Methods: Adult patients admitted to major trauma centre critical care units were enrolled in this 4-week
point-prevalence study. MODS was defined by a daily total Sequential Organ Failure Assessment (SOFA)
score of more than 5. Hierarchical clustering of SOFA scores over time was used to identify MODS
subtypes.
Results: Some 440 patients were enrolled, of whom245 (55⋅7 per cent) developedMODS.MODS carried
a high mortality rate (22⋅0 per cent versus 0⋅5 per cent in those without MODS; P< 0⋅001) and 24⋅0 per
cent of deaths occurred within the first 48h after injury. Three patterns of MODS were identified, all
present on admission. Cluster 1 MODS resolved early with a median time to recovery of 4 days and a
mortality rate of 14⋅4 per cent. Cluster 2 had a delayed recovery (median 13days) and a mortality rate of
35 per cent. Cluster 3 had a prolonged recovery (median 25days) and high associated mortality rate of 46
per cent. Multivariable analysis revealed distinct clinical associations for each form of MODS; 24-hour
crystalloid administration was associated strongly with cluster 1 (P = 0⋅009), traumatic brain injury with
cluster 2 (P = 0⋅002) and admission shock severity with cluster 3 (P = 0⋅003).
Conclusion: Contemporary MODS has at least three distinct types based on patterns of severity and
recovery. Further characterization of MODS subtypes and their underlying pathophysiology may lead to
future opportunities for early stratification and targeted interventions.
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Introduction
Multiple organ dysfunction syndrome (MODS) is common
in critically injured patients who survive the initial insult,
and is associated with poor outcomes1. MODS is respon-
sible for a large proportion of the healthcare resources
associated with acute trauma care2. As early-phase man-
agement strategies such as damage control resuscitation
have been introduced and more injured patients are sur-
viving to reach critical care, the nature of MODS appears
to be changing3. Reports of differences in patterns of
evolution, severity and outcome are challenging the previ-
ously accepted clinical concepts of ‘early and late onset’ or
bimodal peaks of MODS4–9. Determining the incidence,
pattern and outcomes of MODS in the modern era may
help to identify therapeutic opportunities and inform study
design for future research.
With more early survivors of severe injury, MODS
remains a determinant of poor outcomes and a continued
challenge for trauma systems2,7. The pathophysiology of
MODS is a subject of debate in the literature. Some of
the uncertainty may be due to the existence of discrete
forms of MODS with unique pathophysiologies. Recent
studies4,10,11 have described protracted forms of MODS
associated with ageing, immunosuppression, infection and
catabolism. The national incidence of these contempo-
rary MODS subtypes, their resource use and associated
outcomes are not known. Characterizing these different
MODS subtypes is important if progress is to be made
in understanding their underlying pathophysiologies, in
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developing new diagnostic and therapeutic approaches, and
for the design of clinical studies to test them.
The overall aim of this study was to characterize con-
temporary MODS subtypes in trauma critical care at a
population level. The primary aim was to establish the
overall incidence of MODS, and to describe patterns of
severity and recovery, and their associated outcomes. Sub-
sequent aims were to examine different patterns of MODS
onset and recovery, and describe admission characteristics
associated with any MODS subtypes identified.
Methods
England, Wales and Scotland have an organized system
of regional trauma networks, each with a major trauma
centre (MTC) (level I equivalent) designated to man-
age the most severely injured patients in a geographi-
cal region. In the UK, MTCs should adhere to trauma
resuscitation guidelines from the National Institute for
Health and Care Excellence12. All MTCs were invited
to participate, and injured adult patients (aged at least
16 years) requiring admission to a critical care unit between
00⋅01 hours on 1 June and 23⋅59 hours on 30 June 2016
were eligible for inclusion. Study approval was provided by
the National Health Service Research Ethics Committee
(REC), Health Research Authority and Scotland REC A
(reference 15/SS/0170). Patients were enrolled in the study
after admission to critical care, and informed consent was
obtained from the patient or a consultee.
Study procedures
Procedures and training were provided via the Organ
Dysfunction in Trauma (ORDIT) study webpages13. Data
on demographic characteristics, injury severity, admission
physiology and resuscitation in the first 24 h were recorded.
Patients were reviewed daily in critical care until discharge
or death.
Definitions
The presence and evolution of MODS was determined
based on Sequential Organ Failure Assessment (SOFA)
scoring14,15. SOFA was chosen as it is used widely in crit-
ical care internationally. It has been validated for use in
injured patients, including its application from the day
of admission16, and has a good balance of sensitivity and
specificity in predicting unfavourable outcome after severe
injury14. SOFA scores were measured daily from admission
as described in earlier critical care studies16–18.MODSwas
defined by the occurrence of a total SOFA score greater
than 5, affecting two or more organs1,4,19. Recovery was
deemed to have occurred when the SOFA score fell and
remained below 6. Traumatic brain injury (TBI) was diag-
nosed when the head Abbreviated Injury Score was 3 or
higher. Secondary outcomes were in-hospital mortality,
time spent on ventilator, and duration of critical care and
total hospital stay.
Statistical analysis
Categorical variables were analysed using the χ2 or Fisher’s
exact test. Continuous data had a non-normal distribu-
tion according to the Shapiro–Wilk test, and were eval-
uated by means of non-parametric Mann–Whitney U and
Kruskal–Wallis tests. Multiple comparisons of individual
pairs were done with Bonferroni corrections. Unsupervised
hierarchical clustering was performed to define MODS
cohorts using Morpheus online software (Broad Institute,
Massachusetts, USA). Previous clinical studies18,20,21 have
used hierarchical clustering analysis to classify patients
within a population into discrete clusters or phenotypes
on the basis of clinical data. Raw total SOFA score data
for each patient on each of days 1–28 (or day of dis-
charge from critical care or death, if earlier) were entered
into the data matrix. A SOFA score of 0 was assigned on
discharge from the ICU (unless the patient was readmit-
ted). For patients who died during the 28-day interval,
no score was allocated after the date of death. These data
were treated as missing in the clustering analysis and were
excluded from all computations involving the rows within
which they occurred. Heatmaps were generated using
the Euclidean distance between observations and com-
plete linkage between clusters. Complete linkage has been
reported to produce more meaningful separation between
clusters than average linkage22,23 and standard Grubbs’ test
was used to identify outliers24. The number of clusters was
chosen subjectively by selecting a single threshold height
that maintained a reasonable subcluster sample size. The
sensitivity and specificity of the clusters’ ability to detect
MODS on each day was used to determine serial Youden
indices and reported as sensitivity+ specificity− 1.
Multivariable logistic regression models were used to
describe the association between admission or treatment
variables and MODS. Variables with P< 0⋅100 in uni-
variable testing were entered into the regression analysis.
Results are presented as odds ratios (ORs) with 95 per cent
confidence intervals. The calibration and goodness of fit
of the logistic regression models were evaluated using the
χ2 Hosmer–Lemeshow (HL) test, and model discrimi-
nation was assessed by means of area under the receiver
operating characteristic curve (AUROC). Correlations
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Table 1 Admission characteristics, injuries and outcomes
Cluster 1
No MODS
(n = 195)
Cluster 1
MODS
(n = 167)
Cluster 2
MODS
(n = 54)
Cluster 3
MODS
(n = 24)
All MODS
(n = 245)
Admission variables
Age (years)* 48 (29–63) 47 (29–68) 47 (28–60) 42 (28–57) 47 (29–65)
Sex ratio (M : F) 140 : 55 122 : 45 43 : 11 20 : 4 185 : 60
Blunt injury 166 (85⋅1) 151 (90⋅4) 51 (94) 20 (83) 222 (90⋅6)
First GCS score* 14 (9–15) 14 (6–15) 12 (4–15) 14 (9–15) 13 (6–15)†
First systolic BP measurement (mmHg)* 127 (107–141) 125 (103–145) 125 (110–143) 128 (110–144) 125 (104–145)
<90 11 (5⋅6) 19 (11⋅4) 2 (4) 2 (8) 23 (9⋅4)
First base deficit measurement (mEq/l)* 0 (–1⋅2 to 1⋅1) 0 (–1⋅1 to 5⋅1) 0 (–0⋅2 to 5⋅0) 7⋅5 (0⋅3 to 11⋅1) 0⋅1 (0⋅4–6⋅7)†
Crystalloid (l per 24 h)* 1⋅2 (1⋅0–2⋅0) 3⋅0 (2⋅0–4⋅5) 2⋅3 (1⋅7–3⋅8) 3⋅7 (2⋅2–5⋅0) 2⋅9 (2⋅0–4⋅5)†
RBC (units per 24 h)* 3 (2–4) 4 (2–6) 4 (2–7) 4 (2–11) 4 (2–7)†
FFP (units per 24 h)* 3 (2–4) 4 (2–8) 4 (2–6) 4 (2–8) 4 (2–8)†
FFP : RBC ratio* 0⋅1 (0–0⋅6) 0⋅6 (0–1⋅0) 0⋅5 (0–1⋅0) 0⋅5 (0–0⋅8) 0⋅5 (0–1⋅0)
Traumatic brain injury 31 (15⋅9) 56 (33⋅5) 34 (63) 9 (38) 99 (40⋅4)†
Injury Severity Score* 17 (9–26) 25 (16–33) 29 (25–43) 31 (19–45) 25 (18–36)†
APACHE II score* 9 (6–13) 14 (10–19) 15 (10–22) 18 (11–24) 14 (10–20)
Outcomes
Death 1 (0⋅5) 24 (14⋅4) 19 (35) 11 (46) 54 (22⋅0)
Time on ventilator (days)* 1 (1–2) 3 (1–5) 11 (10–15) 16 (12–24) 4 (2–11)
Duration of critical care stay (days)* 3 (2–5) 7 (4–14) 20 (16–27) 36 (32–47) 11 (5–19)
Total duration of hospital care (days)* 9 (5–20) 22 (12–33) 39 (25–62) 53 (39–104) 26 (13–40)
Values in parentheses are percentages unless indicated otherwise; *values are median (i.q.r.). Only 21 patients (4⋅8 per cent) received colloids; median
amount in all groups was 0 (0–0) l per 24 h. MODS, multiple organ dysfunction syndrome; GCS, Glasgow Coma Scale; RBC, red blood cells; FFP, fresh
frozen plasma; APACHE II, Acute Physiology And Chronic Health Evaluation II. †Variables with P< 0⋅100 in univariable analysis of all MODS group
versus no MODS, or comparisons between clusters 1–3 (χ2 or Fisher’s exact test for categorical variables; Mann–Whitney U test for continuous variables)
were entered into multivariable models.
between crystalloid use and MODS were described using
Spearman’s rank correlation coefficients.
Data analysis was conducted using SPSS® version 21
(IBM, Armonk, New York, USA).
Results
All 29 adult major trauma centres in England, Wales and
Scotland participated in the study. In total, 446 patients
were admitted to critical care during the 1-month period,
of whom six died within the first 24 h after injury. Of
the remaining 440 patients, 245 (55⋅7 per cent) developed
MODS (Table 1). The onset of MODS was on the day of
admission in the majority of patients (94⋅3 per cent). The
remainder developedMODS on day 2 (5⋅3 per cent) or day
3 (0⋅4 per cent). Only two patients experienced a second
episode of MODS, one on day 7 and one on day 11. The
mean admission SOFA score was 8⋅5 (95 per cent c.i. 8⋅2
to 8⋅8), and severity peaked on day 2 with a score of 8⋅8
(8⋅5 to 9⋅1). Respiratory and cardiovascular dysfunction
were the greatest contributors to MODS (97⋅1 per cent
and 91⋅0 per cent of patients), followed by central nervous
system (CNS) dysfunction (88⋅1 per cent). Coagulation
dysfunction affected 57⋅5 per cent; liver and renal systems
had the lowest incidence of dysfunction (36⋅7 and 26⋅7 per
cent respectively). Organ dysfunction patterns were similar
in patients with and without TBI (Table S1, Figs S1 and S2,
supporting information).
Some 22⋅0 per cent of patients with MODS died, com-
pared with 0⋅5 per cent of the group without MODS
(Table 1). Among the 310 patients (70⋅5 per cent) with-
out TBI, the mortality rate in those with MODS was 15⋅1
per cent, compared with 0⋅6 per cent in those without
MODS (Table S1, supporting information). The overall
median time to death in patients with MODS was 6 (i.q.r.
2–10) days and 24⋅0 per cent of all MODS deaths occurred
within the first 48 h. For survivors, the median time with
MODS was 10 (i.q.r. 5–17) days. In total, the 245 patients
with MODS used 2656 critical care bed-days and spent
5872 days in hospital.
Hierarchical clustering analysis of daily SOFA scores
identified three high-level clusters of different patient
recovery patterns (Fig. 1). Cluster 1 was the largest with
362 patients, of whom167 developedMODS (68⋅2 per cent
© 2019 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2020; 107: 402–412
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Fig. 1 Unsupervised hierarchical clustering of sequential organ failure assessment scores from admission to day 28
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Shades of red within the heatmap indicate patients with multiple organ dysfunction (MODS), defined by a Sequential Organ Failure Assessment (SOFA)
score of 6 or higher. Patients discharged from critical care were assigned a score of 0 (blue). Patients who died within 28 days had missing scores after the
date of death (black). Dashed line indicates the level of dendrogram transection used for analysis.
of all patients with MODS). All 54 patients in cluster 2
developed MODS (22⋅0 per cent), as did the 24 patients
in cluster 3 (9⋅8 per cent). Admission SOFA scores for
patients with MODS were higher in clusters 2 and 3: mean
SOFA score on day 1: 7⋅7 in cluster 1 versus 8⋅9 in clus-
ter 2 (P = 0⋅002) and 10⋅9 in cluster 3 (P< 0⋅001). SOFA
scores for patients with MODS in cluster 1 began improv-
ing immediately, and in survivors had fallen below MODS
thresholds by day 5. SOFA scores initially worsened for
patients in clusters 2 and 3 before beginning to resolve from
day 3; they did not fall below admission levels until day 5
(Fig. 2a). Patterns of recovery did not appear to be affected
by the presence of TBI (Fig. 2b). MODS took longer to
resolve in patients in cluster 2 (median 13 (i.q.r.12–16)
days), whereas those in cluster 3 had a very protracted dura-
tion of organ dysfunction (25 (19–28) days) (Fig. 2c).
MODS had resolved in 71⋅9 per cent of patients (120
of 167) in cluster 1 by day 7, and no patient in this cluster
still had MODS after 11 days. Patients with MODS in
cluster 1 were best discriminated from those in clusters 2
and 3 by their MODS status on day 8. Some 88 per cent
of patients still with MODS on day 8 were in clusters 2 or
3 (sensitivity 99 per cent, specificity 93 per cent for being
in clusters 2/3, Youden index 0⋅91). Day 18 was the best
discriminator between patients in clusters 2 and 3; 79 per
cent of patients who still had MODS on day 18 were in
cluster 3 (sensitivity 85 per cent, specificity 94 per cent for
being in cluster 3, Youden index 0⋅78).
The clusters also had different outcome profiles. Patients
with MODS in cluster 1 had a mortality rate of 14⋅4 per
cent, rising to 35 per cent in cluster 2 (P< 0⋅001) and 46
per cent in cluster 3 (P< 0⋅001) (Table 1). The duration of
critical care stay for patients in cluster 3 was double that of
those in cluster 2 (36 and 20 days respectively; P< 0⋅001)
and hospital stay was almost 40 per cent longer (53 versus
39 days; P = 0⋅030) (Table 1).
Admission characteristics associated with the develop-
ment of MODS in each cluster were analysed. MODS
cluster 1 was the only cluster in which the development
of MODS was not associated with injury severity (Table 2),
despite high Injury Severity Scores (median 25) (Table 1).
The cluster 1 MODS group was most strongly associated
© 2019 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2020; 107: 402–412
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Fig. 2 Multiple organ dysfunction syndrome development, recovery and associations
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Table 2 Multivariable logistic regression analysis of factors associated with the development of multiple organ dysfunction syndrome
Cluster 1 MODS (n = 167) Cluster 2 MODS (n = 54) Cluster 3 MODS (n = 24) All MODS (n = 245)
Odds ratio P Odds ratio P Odds ratio P Odds ratio P
First GCS score 1⋅02 (0⋅91, 1⋅09) 0⋅960 0⋅93 (0⋅85, 1⋅01) 0⋅091 – 1⋅06 (0⋅92, 1⋅20) 0⋅374
First base deficit measurement 1⋅02 (0⋅96, 1⋅09) 0⋅424 0⋅99 (0⋅92, 1⋅07) 0⋅851 1⋅11 (1⋅01, 1⋅21) 0⋅003 1⋅04 (0⋅94, 1⋅16) 0⋅408
Crystalloid (l per 24 h) 1⋅32 (1⋅07, 1⋅63) 0⋅009 0⋅99 (0⋅81, 1⋅21) 0⋅928 1⋅24 (1⋅03, 1⋅51) 0⋅019 3⋅09 (1⋅76, 5⋅43) < 0⋅001
RBC (units per 24 h) 1⋅02 (0⋅91, 1⋅13) 0⋅705 – – 1⋅22 (0⋅98, 1⋅51) 0⋅069
FFP (units per 24 h) 1⋅12 (0⋅86, 1⋅45) 0⋅370 – – 1⋅16 (0⋅73, 1⋅83) 0⋅516
Traumatic brain injury 2⋅00 (0⋅66, 6⋅10) 0⋅474 3⋅5 (1⋅57, 7⋅82) 0⋅002 0⋅98 (0⋅35, 2⋅06) 0⋅973 4⋅29 (0⋅39, 46⋅80) 0⋅232
Injury Severity Score 1⋅01 (0⋅93, 1⋅03) 0⋅513 1⋅03 (1⋅00, 1⋅06) 0⋅015 1⋅03 (1⋅00, 1⋅06) 0⋅036 1⋅06 (1⋅01, 1⋅10) 0⋅007
Values in parentheses are 95 per cent confidence intervals. Variables with P< 0⋅100 in univariable analysis of all multiple organ dysfunction syndrome
(MODS) group versus no MODS, or comparisons between clusters 1–3 were entered into multivariable models. GCS, Glasgow Coma Scale; RBC, red
blood cells; FFP, fresh frozen plasma. Cluster 1 model: area under receiver operating characteristic curve (AUROC) 0⋅79 (95 per cent c.i. 0⋅61 to 0⋅88),
Hosmer–Lemeshow (HL) χ2 = 5⋅8, P = 0⋅664; cluster 2 model: AUROC 0⋅73 (0⋅63 to 0⋅82), HL χ2 = 4⋅4, P = 0⋅811; cluster 3 model: AUROC 0⋅80 (0⋅72
to 0⋅88), HL χ2 = 7⋅0, P = 0⋅535; all MODS model: AUROC 0⋅91 (0⋅85 to 0⋅97), HL χ2 = 8⋅9, P = 0⋅347.
Fig. 3 Multiple organ dysfunction syndrome by site and crystalloid use
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with the volume of crystalloid administered within the first
24 h (OR 1⋅32) (Table 2 and Fig. 2d). Cluster 2 contained
the greatest proportion of patients with TBI (63 per cent)
(Fig. 2e) and brain injury was strongly associated with
this cluster (OR 3⋅51) (Table 2). Cluster 3 was the only
MODS subtype with patients shocked on arrival (median
base deficit 7⋅5 versus 0mEq/l in all other MODS clusters;
P = 0⋅004) (Fig. 2f ). Both admission base deficit and 24-h
crystalloid use were independently associated with the
development of prolonged MODS in cluster 3 (OR 1⋅11,
P = 0⋅003, and OR 1⋅24, P = 0⋅019 respectively) (Table 2).
The median volume of crystalloid administered in
patients with MODS varied across sites from 1 to 5⋅2
litres, whereas the incidence of MODS ranged from 8 to
100 per cent (Fig. 3a; Table S2, supporting information).
There was a strong correlation between crystalloid use at
individual sites and the development of MODS in cluster
1 (rS = 0⋅66, P< 0⋅001). A modest correlation was seen
in cluster 3 (rS = 0⋅56, P = 0⋅001), but not in cluster 2
(rS = 0⋅15, P = 0⋅424) (Fig. 3b). Overall, MODS resolved
in a shorter time among patients who received less than 1⋅5
litres of crystalloid in the first 24 h than in those receiving
greater volumes (Fig. 3c). By day 8 after injury almost twice
the proportion of patients who had received more than 1⋅5
litres of crystalloid still had MODS compared with those
who had received 1⋅5 litres or less (36⋅0 versus 19⋅0 per
cent; P = 0⋅010). The median duration of critical care stay
was longer for patients with MODS who received more
than 1⋅5 litres of crystalloid in the first 24 h (7 versus 5 days;
P< 0⋅001) (Table S3, supporting information).
Discussion
This was a national point-prevalence study of MODS after
traumatic injury in the era of contemporary damage control
resuscitation, neurocritical care and regional trauma sys-
tems. MODS was common in this critical care population
and had a high associatedmortality rate and resource use. A
total of 7604 injured patients were admitted to critical care
units in England and Wales in 2016 (Trauma Audit and
Research Network, personal communication). It would be
predicted nationally to be over 3300 injured patients in
critical care with MODS annually, requiring 33 000 critical
care bed-days, of whom 750 will die. Survivors will require
63 750 days in hospital overall, and may suffer long-term
impairment to physical and psychological outcomes25.
Overall outcomes appear to have improved for patients
with MODS in comparison to those described in previous
studies. The mortality rate of 22⋅0 per cent among patients
with MODS in the present study compares with 33–36
per cent in a study from the Glue Grant consortium in
the USA, which examined temporal trends in patients with
MODSbetween 2003 and 20102. In the present study there
was a preponderance of cardiovascular dysfunction in the
initial days after injury. Given that 24⋅0 per cent of deaths
occurred in this time frame, it may be that cardiovascular
dysfunction is the major component of MODS in the
damage control resuscitation era.
MODS appeared to be present in injured patients on the
first day of admission and had at least three distinct recov-
ery patterns: an early resolving form and two persistent
types. In cluster 1, MODS had resolved in 31 patients (7⋅0
per cent of 440 study patients) within the first 48 h, and
this group would not have been included in other studies
that defined MODS as occurring after day 2. In contrast,
nearly one-third of patients with MODS in this study
had a prolonged form (cluster 2 or 3) taking a median of
15 days to resolve. Historically, MODS has had a bimodal
distribution, with a second peak in incidence occurring
between 7 and 14 days after injury26. This second peak has
been declining9 and appears to have all but disappeared
in contemporary MODS, with only three patients in the
present study developing MODS after day 3. Contempo-
rary MODS is characterized by respiratory, cardiovascular
and haemostatic dysfunction. Respiratory and cardiovas-
cular dysfunction were nearly universal in these patients
with MODS, whereas older studies2 have described
involvement of these organ systems at around 50 per cent.
Patients with different recovery trajectories were indis-
tinguishable on admission solely by examination of total
or component SOFA scores, but there were differences
in injury patterns, shock severity and early management
associated with the subsequent development of the MODS
subtypes.
Crystalloid use in the first 24 h after injury was the only
clinical variable associated with the cluster 1 early resolving
MODS subtype. Crystalloids are known to have proinflam-
matory effects on coagulation and the endothelium27–29,
and volume administered is associated with increased
organ injury such as acute respiratory distress syndrome
and abdominal compartment syndrome. Previous trauma
studies30,31 reported a link between organ dysfunction and
administration of large volumes of crystalloid in the first 12
or 24 h after injury. Current national trauma haemorrhage
guidance32 reflects this, recommending that crystalloids
are avoided during damage control resuscitation. It is likely
therefore that the majority of crystalloid administration
occurs in the critical care unit. Only fluid use in the first
24 h was examined, but this volume replacement may per-
sist for some days.. Further research is needed to explore
causality in this relationship and identify optimal strategies
for ongoing volume replacement in these patients.
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TBI characterized the group of patients whose MODS
tended to persist, with a delayed recovery between days
8 and 18. Brain injury is thought to potentially confound
the assessment of MODS and its resolution14,33. In the
present study, there was little to differentiate patients with
and without MODS in terms of severity or pattern of TBI.
However, patients with TBI and MODS appear to have a
specific, separate clinical trajectory, not limited to the CNS
component of the SOFA score alone. Further investigation
is required to determine whether this is due to extracra-
nial effects of TBI or current management paradigms.
For example, endogenous or exogenous catecholamines
have both been postulated as responsible for some of the
observed effects34–36. The presence of MODS is known
to worsen outcomes for those with severe TBI37,38, so
research focusing on this specific group of patients may
elucidate underlying mechanisms and lead to real improve-
ments for patients with brain injury.
Patients in cluster 3 with the prolonged form of MODS
were the smallest cohort, but had the worst outcomes
and consumed a disproportionate amount of critical care
resources. Previous studies39,40 of indolent immunosup-
pressive dysfunction have focused on elderly patients, but
there was no difference in age between MODS clusters in
the present study. Shock on admission was only associated
with the subsequent development of prolonged MODS
found in cluster 3. There was a weaker association with
crystalloid administration in this group than in cluster 1,
and there was no association with the volume of blood
product administration. These results suggest that the per-
sistent MODS in patients in cluster 3 may be due to an
early response to the shocked state, and not a later conse-
quence of resuscitation. Prolonged MODS may represent
the contemporary form of classical multiple organ failure,
driven by dysregulation of the inflammatory response to
injury41. Developing biomarkers and stratification tools to
identify these patients early in the clinical course may allow
the development of new management strategies and thera-
peutic opportunities for MODS after injury.
There are a number of limitations to this study. Although
wide ranging geographically, it was limited in its accrual
period and the number of data points obtained for each
patient. In particular, it was not possible to capture the
number and nature of infectious episodes or other com-
plications that may have contributed to prolongedMODS.
It was not possible to assign cause of death, which would
have provided insight into whether and how MODS con-
tributed to the death of each patient. In the hierarchical
clustering analysis, selection of the number of clusters to
analyse was based on determination of adequate cluster size
for intergroup analyses. Further subtypes may be identified
from deeper analysis of larger cohorts of patients. Although
the majority of deaths in the early resolving MODS group
occurred within 48 h, the patterns of death for the differ-
ent clusters require further evaluation. SOFA scoring dif-
fers from other MODS scores (such as the Denver42 or
Goris43 score) as it includes CNS and coagulation com-
ponents, which may lead to differences in reported inci-
dence of MODS33, and may partly account for differences
in proportion of MODS in the present analysis com-
pared with other studies. However, the use of SOFA in
severely injured and TBI populations has good discrimina-
tive ability, and balance of sensitivity and specificity in pre-
dicting unfavourable outcome for injured patients14,44. In
the present multivariable analyses examining associations
between clinical variables and the development of MODS,
there was potential overlap between SOFA components as
both admission (input) and later SOFA (output) variables,
such as the Glasgow Coma Scale (GCS). GCS was not
associated with the development of MODS, whereas the
anatomical presence of a head injury was associated with
MODS development only in cluster 2. The authors there-
fore believe that the findings provide a robust signal for
the associations across each cluster analysis. In this observa-
tional study, however, it was only possible to identify asso-
ciations between clinical variables and MODS; causation
could not be determined. There were only 24 patients with
MODS in cluster 3, which may have led to model overfit.
Larger cohort studies are required to explore these smaller
cohorts, and potential further subcluster divisions. Finally,
the multicentre nature of this study may mean that treat-
ment policies differed despite national guidance, so this
study represents clinically focused descriptors of MODS
subtypes rather than ones driven by biology alone.
MODS is still common in the era of damage control
resuscitation, and has a high associated mortality rate and
resource use. Contemporary MODS is now almost always
present from admission, commonly involves cardiovascu-
lar dysfunction, and has subtypes with different patterns
of recovery. Patients who develop persistent MODS are
difficult to identify on admission based on their clinical
characteristics. The development of tools for the early
identification of these subtypes requires further research
on their individual initiating mechanisms.
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